Cost-Effectiveness of Monotherapy versus Polypharmacy in Cervicobrachial Symptoms: A Nationwide Multicenter Analysis

20260 citationsJournal Articlediamond Open Access

Authors

Sadayuki Ito · Nagoya University

Hiroaki Nakashima · Nagoya University

Norimitsu Wakao · Aichi Medical University

Takeo Furuya · Chiba University

Toshitaka Yoshii · Tokyo Medical and Dental University

Hideyuki Arima · Hamamatsu University School of Medicine

Yu Yamato ·

Abstract

Introduction: Cervicobrachial symptoms are common causes of disability worldwide, yet the cost-effectiveness of combination therapy versus monotherapy remains unclear. In this nationwide multicenter study, we aimed to compare the economic value of multiple-drug therapy with that of monotherapy for cervicobrachial symptoms.

Topics & Keywords

Cervical and Thoracic Myelopathy Musculoskeletal pain and rehabilitation Botulinum Toxin and Related Neurological Disorders

Publication Details

Published in: Spine Surgery and Related Research

DOI: 10.22603/ssrr.2025-0304

Field-Weighted Citation Impact: 0.00

Command Palette

Cost-Effectiveness of Monotherapy versus Polypharmacy in Cervicobrachial Symptoms: A Nationwide Multicenter Analysis

Authors

Abstract

Topics & Keywords

Publication Details